A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alexandra Dreyzin, M.D.
National Cancer Institute (NCI)
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Children'S Hospital of Los Angeles
Los Angeles, California, United States
Recruiting - Children'S National Medical Center
Washington D.C., District of Columbia, United States
Recruiting - Children'S Healthcare of Atlanta
Atlanta, Georgia, United States
Not, yet, recruiting - National Institutes of Health Clinical Center
Bethesda, Maryland, United States
Recruiting - Dana-Farber/boston Children S Hospital
Boston, Massachusetts, United States
Not, yet, recruiting - Huntsman Cancer Institute, University of Utah
Salt Lake City, Utah, United States
Recruiting - Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
Recruiting - Seattle Children'S, University of Washington
Seattle, Washington, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Jul 2026
- Primary completion
- 31 Dec 2026
- Completion
- 31 Dec 2027
- Last update posted
- 10 Jul 2026
- Registered enrollment
- 60
- Registry id
- NCT05621291
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.